This educational supplement discusses updated treatment guidelines for bacterial vaginosis (BV) and reviews literature on the association of BV and the risk of sexually transmitted infections that supports the need for proper BV treatment, whether symptomatic or asymptomatic.
Download the supplement
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Read More
Study finds lack of testing for gonorrhea, chlamydia during pregnancy
August 15th 2024Adherence to guideline-based laboratory testing and treatment of chlamydia and gonorrhea in pregnant women has been found to be suboptimal in the United States, indicating the potential for negative effects on newborn and maternal health.
Read More